This is consistent with the results obtained by a previous study showing that the upregulation of EIF5A2 during oral squamous cell carcinoma progression and lymph node metastasis predicted EIF5A2 as a possible new biomarker [33]. Here, EIF5A2 is linked to oral cavity squamous cell carcinoma.